Quanterix Corporation (QTRX) Stock

Quanterix Corporation (QTRX) is a Technology stock trading at $3.39 (as of 2026-06-18), with a market capitalization of $144.14M and a trailing P/E of -1.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Quanterix develops and markets digital immunoassay platforms for life sciences research and diagnostics, including the HD-X, SR-X, and SP-X instrument systems. It also supplies assay kits and related reagents and offers services such as sample testing and custom assay development for academic and governmental labs as well as pharmaceutical and biotechnology customers.

Valuation — source: SEC EDGAR (first-party)
Price	$3.39
Market Cap	$144.14M
P/E Ratio	-1.3
EV / EBITDA	-0.8
Price / Book	0.51
Price / Sales	0.99
DCF Value (model)	$-28.25
DCF Upside vs Price	-933.3%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$138.90M
Net Margin	-77.1%
Return on Equity	-36.9%
Current Ratio	3.72
Revenue Growth (YoY)	1.1%
EPS Growth (YoY)	151.0%
FCF Growth (YoY)	107.2%

Financial Health — source: SEC EDGAR
Altman Z-Score	-1.42 (distress)

Valuation vs Sector & Industry
Stock P/E	-1.3
Sector P/E (Technology)	32.6
Industry P/E (Measuring & Control Equipment)	60.1
vs Sector	-104.0%
vs Industry	-102.2%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	VANGUARD GROUP INC ($17.03M)
Institutional Holders Tracked	10

Company
Sector	Technology
Industry	Measuring & Control Equipment
CEO	Everett V. Cunningham
Employees	471
Country	US
IPO Date	2017-12-07

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.